Crestline Management LP lowered its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 5.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,660,732 shares of the company’s stock after selling 300,000 shares during the period. Denali Therapeutics makes up 10.3% of Crestline Management LP’s holdings, making the stock its biggest position. […]